Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 29 June

Sophia Mavridis
June 29, 2022

Morning Bell 28 June

Paulina Peters
June 28, 2022

Morning Bell 27 June

Sophia Mavridis
June 27, 2022

Weekly Wrap 24 June

Sophia Mavridis
June 24, 2022

Morning Bell 23 June

Paulina Peters
June 23, 2022

Morning Bell 22 June

Sophia Mavridis
June 22, 2022

Morning Bell 21 June

Paulina Peters
June 21, 2022

Morning Bell 20 June

Sophia Mavridis
June 20, 2022

Weekly Wrap 17 June

Sophia Mavridis
June 17, 2022

Morning Bell 16 June

Paulina Peters
June 16, 2022